Come up with a name for your new list and we'll add to it:
Actelion raised a round of funding on June 16, 2017. Investors include
Johnson & Johnson.
Actelion Pharmaceuticals is a biopharmaceutical company headquartered in Allschwil/Basel, Switzerland, focusing on the discovery, development and commercialization of innovative treatments to serve hi…